Lathrop GPM LLP Partner Lisa Hillman Joins Panel at ACI Advanced Summit on Life Sciences Patents
NEW YORK (MAY 19, 2023) – Lathrop GPM LLP Partner Lisa Hillman, Ph.D., joined a panel at the American Conference Institute’s 21st Advanced Summit on Life Sciences Patents on May 19 in New York City. The panel took place at 10:30 am and was titled CRISPR, CAR T and mRNA: Scrutinizing Recent Life Sciences IP Controversies to Develop a New Way Forward.
Hillman serves as a partner in the firm’s Intellectual Property Practice Group. With over two decades of experience in intellectual property law, her practice encompasses domestic and foreign patent procurement. She also provides strategic patent counseling including patent portfolio management, patent validity opinions, infringement opinions, freedom-to-operate opinions and due diligence reviews. Hillman has broad technical experience in the areas of molecular biology, microbiology, fermentation technologies, human gene therapy, human and veterinary diagnostics, personal diagnostics, proteomics, siRNA technologies, antibody technologies, CRISPR technologies, CAR T-cell technologies, liposomes, biosensors, bioinformatics, personalized medicine, tissue scaffolds, agriculture, orthobiologics, medical devices, immunotherapy, pharmaceuticals and food processing technologies.
ACI’s 21st Advanced Summit on Life Sciences Patents returns to New York City May 18-19 at the New York City Bar Association. This annual conference features discussions, face-to-face workshops and practical guidance, expert insights and best practice tips in the field of patents. The conference is designed to help attendees examine recent life sciences IP controversies and patent rights with new technologies such as mRNA, CAR T and CRISPR. Securing IP rights to these technologies and leveraging or licensing these rights appropriately is essential to successful commercialization, growth, and future development of these innovations.
Learn more about the conference here.